Filter News
Area of Research
- (-) Computational Biology (1)
- (-) Fuel Cycle Science and Technology (1)
- Advanced Manufacturing (2)
- Biology and Environment (41)
- Building Technologies (1)
- Clean Energy (53)
- Climate and Environmental Systems (1)
- Computational Engineering (3)
- Computer Science (16)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (5)
- Fusion Energy (2)
- Isotopes (2)
- Materials (60)
- Materials for Computing (16)
- Mathematics (1)
- National Security (52)
- Neutron Science (20)
- Nuclear Science and Technology (2)
- Quantum information Science (8)
- Supercomputing (134)
News Type
Media Contacts
![ORNL retiree Duane Starr and his wife, Nancy, pose with the critical frequencies demo unit Duane designed, built and donated to the laboratory to support nuclear workshops. Credit: Carlos Jones/ORNL, Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2023-12/2023-P06566.jpg?h=036a71b7&itok=tIETe2jc)
For years, Duane Starr led workshops at ORNL to help others from across the U.S. government understand uranium processing technologies. After his retirement, Starr donated a 5-foot-tall working model, built in his garage, that demonstrates vibration harmonics, consistent with operation of a super critical gas centrifuge rotor, a valuable resource to ongoing ORNL-led workshops.
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.